Doctors finding hurdles to using pills to treat COVID-19


              Jeffrey Carlson stands for a portrait outside his home in Vadnais Heights, Minn., on Sunday, March 13, 2022. Carlson, a Type 1 diabetic with heart stents, contracted COVID-19 in January, but recovered quickly after being treated with Merck's molnupiravir medication. (AP Photo/Nicole Neri)
            
              Jeffrey Carlson stands for a portrait outside his home in Vadnais Heights, Minn., on Sunday, March 13, 2022. Carlson, a Type 1 diabetic with heart stents, contracted COVID-19 in January, but recovered quickly after being treated with Merck's molnupiravir medication. (AP Photo/Nicole Neri)
            
              Jeffrey Carlson stands for a portrait outside his home in Vadnais Heights, Minn., on Sunday, March 13, 2022. Carlson, a Type 1 diabetic with heart stents, contracted COVID-19 in January, but recovered quickly after being treated with Merck's molnupiravir medication. (AP Photo/Nicole Neri)
            
              Jeffrey Carlson stands for a portrait outside his home in Vadnais Heights, Minn., on Sunday, March 13, 2022. Carlson, a Type 1 diabetic with heart stents, contracted COVID-19 in January, but recovered quickly after being treated with Merck's molnupiravir medication. (AP Photo/Nicole Neri)
Doctors finding hurdles to using pills to treat COVID-19